Aide-mémoire - Blood Products and Related Biologicals

Quality and safety of blood products and related substances

Overview

Blood products and related substances used as biological medicines and in vitro diagnostics in human medicine have historically played a paramount role in improving world health. These products constitute a key health concern in both the developing and the developed world, requiring specialized expertise of National Regulatory Authorities (NRAs) and
coordination across national boundaries for their control. The World Health Organization (WHO), in accordance with its constitutional obligation to develop, establish and promote international standards for all biological products is the lead agency globally in this field, coordinating collaboration and consensus on key issues related to the safety and quality
of these products.

WHO Team
Health Product Policy and Standards (HPS)
Number of pages
3